Under these circumstances (e.g., transient insulin resistance during pregnancy), GDM is the result of compromised capacity of pancreatic β‐cells to increase insulin secretion to compensate insulin resistance in insulin‐target tissues (Kuhl, 1991). The gene discussed is INS; the disease is gestational diabetes.